Podcast: The Secretome, Longevity Medicine And Alternatives To GLP-1 Agonists

Podcast: In Conversation With 2024 Rising Leader, Hanadie Yousef

One of In Vivo's 2024 Rising Leaders, Hanadie Yousef, CEO of Juvena Therapeutics, talks about the secretome as a source of therapeutics, the company's lead assets, the future of longevity medicine and learning as you go as a biotech entrepreneur.  

In Vivo Podcast
• Source: Shutterstock

Hanadie Yousef, CEO of Juvena Therapeutics, is one of In Vivo's 2024 Rising Leaders. She co-founded Juvena based on the science of the secretome, the collection of proteins secreted by human stem cells. In this episode, Yousef explains the science behind the secretome, Juvena's platform, the company's lead assets and her experience as a young entrepreneur. 

Timestamp

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Rising Leaders

More from Leadership